In vitro models for human malaria: targeting the liver stage
Open Access
- 29 June 2022
- journal article
- review article
- Published by Elsevier in Trends in Parasitology
- Vol. 38 (9) , 758-774
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI001250-01, R01AI117017, R21AI149730)
- Division of Intramural Research
- Walter Reed Army Institute of Research
This publication has 118 references indexed in Scilit:
- Towards an optimized inhibition of liver stage development assay (ILSDA) for Plasmodium falciparumMalaria Journal, 2013
- Complete Plasmodium falciparum liver-stage development in liver-chimeric miceJournal of Clinical Investigation, 2012
- Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial DrugThe Journal of Infectious Diseases, 2012
- Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug DiscoveryScience, 2011
- Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human HepatocytesDrug Metabolism and Disposition, 2011
- A Plasmodium falciparum Strain Expressing GFP throughout the Parasite's Life-CyclePLOS ONE, 2010
- Resistance to Therapies for Infection byPlasmodium vivaxClinical Microbiology Reviews, 2009
- Identification of a Metabolically Stable Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Antimalarial Activity in MiceJournal of Medicinal Chemistry, 2009
- Heparan Sulfate Proteoglycans Provide a Signal to Plasmodium Sporozoites to Stop Migrating and Productively Invade Host CellsCell Host & Microbe, 2007
- A Plant-Derived Morphinan as a Novel Lead Compound Active against Malaria Liver StagesPLOS Medicine, 2006